MarketCapTrends
CAPR
Capricor Therapeutics Inc. (CAPR)
NASDAQ · Healthcare

Capricor Therapeutics Inc. Shareholder Equity 2011–2025

Capricor Therapeutics Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Capricor Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 305.8M, a 110.22% increase year-over-year.
  • Capricor Therapeutics Inc. shareholder equity for 2025 were 305.8M, a 110.22% increase from 2024.
  • Capricor Therapeutics Inc. shareholder equity for 2024 were 145.5M, a 543.60% increase from 2023.
  • Capricor Therapeutics Inc. shareholder equity for 2023 were 22.6M, a 91.76% increase from 2022.
  • Capricor Therapeutics Inc. shareholder equity for 2022 were 11.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Capricor Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$306
2024$145
2023$23
2022$12
2021$31
2020$28
2019$7
2018$5
2017$11
2016$-4
2015$-1
2014$-6
2013$-1
2012$5
2011$2
Capricor Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$306
2024-12-31$145
2023-12-31$23
2022-12-31$12
2021-12-31$31
2020-12-31$28
2019-12-31$7
2018-12-31$5
2017-12-31$11
2016-12-31$-4
2015-12-31$-1
2014-12-31$-6
2013-12-31$-1
2012-12-31$5
2011-12-31$2

Capricor Therapeutics Inc. Shareholder Equity — FAQ

Capricor Therapeutics Inc. (CAPR) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CAPR's shareholder equity history?

The chart and table above show Capricor Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.